Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antihypertensive Agents"" wg kryterium: Temat


Tytuł:
The prevalence and determinants of blood pressure control among hypertension patients in eastern Zimbabwe: A cross-sectional study.
Autorzy:
Mundagowa PT; Africa University Clinical Research Center, Africa University, Mutare, Zimbabwe.; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States of America.
Zambezi P; Africa University Clinical Research Center, Africa University, Mutare, Zimbabwe.
Muchemwa-Munasirei P; College of Social Sciences, Theology, Humanities and Education, Africa University, Mutare, Zimbabwe.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0293812. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; Middle Aged ; Aged ; Blood Pressure ; Cross-Sectional Studies ; Prevalence ; Zimbabwe/epidemiology
Czasopismo naukowe
Tytuł:
Early blood pressure lowering therapy is associated with good functional outcome in patients with intracerebral hemorrhage.
Autorzy:
Lv X; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Liu X; Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Hu Z; Department of Neurology, People's Hospital of Chongqing Hechuan (PHHC), Chongqing, China.
Deng L; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Li Z; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Cheng J; Department of Neurology and Neurosurgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pu M; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Li Q; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. qili_.; Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. qili_.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Feb 14; Vol. 24 (1), pp. 63. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Cerebral Hemorrhage*/diagnostic imaging
Cerebral Hemorrhage*/drug therapy
Cerebral Hemorrhage*/complications
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/adverse effects
Humans ; Blood Pressure/physiology ; Hematoma ; Tomography, X-Ray Computed ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Antihypertensive medication persistence and adherence among non-Hispanic Asian US patients with hypertension and fee-for-service Medicare health insurance.
Autorzy:
Choi E; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Mizuno H; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.; Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Wang Z; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Fang C; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Mefford MT; Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, California, United States of America.
Reynolds K; Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, California, United States of America.; Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California, United States of America.
Ghazi L; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Shimbo D; The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, United Kingdom.
Muntner P; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300372. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*
Adult ; Humans ; Aged ; United States ; Medicare ; Medication Adherence ; Ethnicity
Czasopismo naukowe
Tytuł:
The safety and efficacy of clevidipine for blood pressure management in neurocritical patients: a systematic review and meta-analysis.
Autorzy:
Widiastuti M; Department of Anesthesiology, Universitas Padjajaran, Bandung, West Java, Indonesia. .; Department of Anesthesiology, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Banten, Indonesia. .; Department of Anesthesiology, Siloam Hospital Lippo Village, Tangerang, Banten, Indonesia. .
Bisri DY; Department of Anesthesiology, Universitas Padjajaran, Bandung, West Java, Indonesia.
Rachman IA; Department of Anesthesiology, Universitas Padjajaran, Bandung, West Java, Indonesia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 16; Vol. 14 (1), pp. 6355. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Antihypertensive Agents*/adverse effects
Hypertension*/drug therapy
Pyridines*
Humans ; Blood Pressure ; Calcium Channel Blockers/adverse effects ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study.
Autorzy:
Everatt R; Laboratory of Cancer Epidemiology, National Cancer Institute, Baublio 3B, Vilnius, LT-08406, Lithuania. .
Kuzmickienė I; Laboratory of Cancer Epidemiology, National Cancer Institute, Baublio 3B, Vilnius, LT-08406, Lithuania.
Brasiūnienė B; Department of Medical Oncology, National Cancer Institute, Vilnius, Lithuania.; Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Vincerževskienė I; Cancer Registry, National Cancer Institute, Vilnius, Lithuania.
Intaitė B; Department of Gynaecologic Oncology, National Cancer Institute, Vilnius, Lithuania.
Cicėnas S; Department of Thoracic Surgery and Oncology, National Cancer Institute, Vilnius, Lithuania.
Lisauskienė I; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Mar 04; Vol. 24 (1), pp. 155. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Ovarian Neoplasms*/drug therapy
Female ; Humans ; Middle Aged ; Aged ; Retrospective Studies ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors.
Autorzy:
Huang D; School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.; State Key Laboratory Breeding Base-Hebei Key Laboratory of Molecular Chemistry for Drug, Shijiazhuang 050018, China.
Chen Y; School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Yang J; School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Zhao B; School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Wang S; School of Food Science and Biology, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Chai T; School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Cui J; Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Zhou X; School of Food Science and Biology, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Shang Z; School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.; State Key Laboratory Breeding Base-Hebei Key Laboratory of Molecular Chemistry for Drug, Shijiazhuang 050018, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Jan 18; Vol. 29 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Aniline Compounds*/pharmacology
Antihypertensive Agents*
Humans ; Apoptosis ; Pyrimidines/pharmacology
Czasopismo naukowe
Tytuł:
Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial.
Autorzy:
Zhao X; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Li X; Department of Epidemiology, XiangYa School of Public Health, Changsha, China.
Liu T; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Yang G; Center of Clinical Pharmacology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.; Department of Clinical Pharmacology, XiangYa School of Pharmaceutical Sciences, Changsha, China.
Chen Y; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Huang M; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Zhao L; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Li X; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China. .
Jiang W; Department of Cardiology, The Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China. .; Hypertension Research Center of Hunan Province, Changsha, Hunan, China. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 13; Vol. 25 (1), pp. 45. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antihypertensive Agents*/adverse effects
Hypertension*/diagnosis
Hypertension*/drug therapy
Humans ; Amlodipine/adverse effects ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Cross-Over Studies ; Double-Blind Method ; Drug Combinations ; Irbesartan/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
Autorzy:
Fan B; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, Patrick Manson Building, 7 Sassoon Road, Hong Kong SAR, China.
Zhao JV; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 1/F, Patrick Manson Building, 7 Sassoon Road, Hong Kong SAR, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Jan 02; Vol. 22 (1), pp. 6. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/genetics
Mental Disorders*
Humans ; Angiotensin-Converting Enzyme Inhibitors ; Calcium Channel Blockers ; East Asian People ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; European People
Czasopismo naukowe
Tytuł:
The Impact of Timing of Fixed Dose Triple Antihypertensive Combinations on Ambulatory Blood Pressure Monitoring Parameters.
Autorzy:
Ileri C; Tavsanli Doc. Dr Mustafa Kalemli State Hospital, Cardiology Clinic, Kutahya, Turkey.
Dogan Z; Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey.
Ozben B; Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey.
Bircan L; Tavsanlı Doc. Dr Mustafa Kalemli State Hospital, Internal Medicine Clinic, Kutahya, Turkey.
Acet A; Tavsanlı Doc. Dr Mustafa Kalemli State Hospital, Internal Medicine Clinic, Kutahya, Turkey.
Sen T; Kutahya Evliya Celebi Education and Research Hospital, Department of Cardiology, Dumlupinar University School of Medicine, Kutahya, Turkey.
Pokaż więcej
Źródło:
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2224941.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Male ; Humans ; Blood Pressure Monitoring, Ambulatory ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Blood Pressure
Czasopismo naukowe
Tytuł:
Association between use of antihypertensives and cognitive decline in the elderly-A retrospective observational study.
Autorzy:
Dhami P; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Alagiakrishnan K; Division of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Senthilselvan A; School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 20; Vol. 18 (12), pp. e0295658. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Antihypertensive Agents*/adverse effects
Antihypertensive Agents*/therapeutic use
Cognitive Dysfunction*/drug therapy
Cognitive Dysfunction*/etiology
Aged ; Aged, 80 and over ; Humans ; Dementia/drug therapy ; Dementia/epidemiology ; Dementia/diagnosis ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies